Study Of Mul-1867 A Drug Candidate For Inhalation Therapy Of MRSA/VRSA Infections In Patients With Cystic Fibrosis In Murine Lung Infection Model

European Cystic Fibrosis Conference 2017 (June 07-10, 2017, Seville, Spain)

Study Of Mul-1867 A Drug Candidate For Inhalation Therapy Of MRSA/VRSA Infections In Patients With Cystic Fibrosis In Murine Lung Infection Model